Pharma Reaserch Prod Co Ltd Total Liabilities
Pharma Reaserch Prod Co Ltd total liabilities. Based on the latest financial reports, Pharma Reaserch Prod Co Ltd (214450) has total liabilities worth ₩320.01 Billion KRW (≈ $216.87 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Pharma Reaserch Prod Co Ltd (214450) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Pharma Reaserch Prod Co Ltd (2015–2025)
Total liabilities of Pharma Reaserch Prod Co Ltd from 2015 to 2025. This chart illustrates how Pharma Reaserch Prod Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Pharma Reaserch Prod Co Ltd to see how much of total assets are deployed in long-term investments.
Pharma Reaserch Prod Co Ltd Competitors by Total Liabilities
The table below lists competitors of Pharma Reaserch Prod Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SkiStar AB (publ)
ST:SKIS-B
|
Sweden | Skr5.60 Billion |
|
First Tracks Biotherapeutics
NASDAQ:TRAX
|
USA | $14.34 Million |
|
Global Blue Group Holding Ltd
NYSE:GB
|
USA | $1.03 Billion |
|
Suzhou Crystal Clear Chemical Co Ltd
SHE:300655
|
China | CN¥1.45 Billion |
|
China National Accord Medicines Corp Ltd
SHE:000028
|
China | CN¥29.01 Billion |
|
Neutron Holdings, Inc. Common Stock
NASDAQ:LIME
|
USA | $493.56 Million |
|
Grupo Security
SN:SECURITY
|
Chile | CL$14.80 Trillion |
|
China Aluminum International Engineering Corp Ltd
SHG:601068
|
China | CN¥31.41 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Pharma Reaserch Prod Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Pharma Reaserch Prod Co Ltd total assets.
Liquidity & Leverage Metrics
Pharma Reaserch Prod Co Ltd Total Liabilities Ratios Explained
Pharma Reaserch Prod Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharma Reaserch Prod Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharma Reaserch Prod Co Ltd (2015–2025)
The table below shows the annual total liabilities of Pharma Reaserch Prod Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩320.01 Billion ≈ $216.87 Million |
+11.79% |
| 2024-12-31 | ₩286.26 Billion ≈ $193.99 Million |
+291.67% |
| 2023-12-31 | ₩73.09 Billion ≈ $49.53 Million |
-45.68% |
| 2022-12-31 | ₩134.55 Billion ≈ $91.18 Million |
+10.10% |
| 2021-12-31 | ₩122.20 Billion ≈ $82.82 Million |
+64.23% |
| 2020-12-31 | ₩74.41 Billion ≈ $50.43 Million |
+22.28% |
| 2019-12-31 | ₩60.85 Billion ≈ $41.24 Million |
+0.47% |
| 2018-12-31 | ₩60.56 Billion ≈ $41.04 Million |
+494.87% |
| 2017-12-31 | ₩10.18 Billion ≈ $6.90 Million |
+32.38% |
| 2016-12-31 | ₩7.69 Billion ≈ $5.21 Million |
-38.76% |
| 2015-12-31 | ₩12.56 Billion ≈ $8.51 Million |
-- |
About Pharma Reaserch Prod Co Ltd
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly… Read more